跳至主要内容
临床试验/EUCTR2008-003877-42-DK
EUCTR2008-003877-42-DK进行中(未招募)1 期

Relapse prevention in patients with major depression treated with electroconvulsive therapy using a fixed dose range of escitalopram compared to a fixed dose of nortriptyline (DUAG-7)A randomised controlled 6 month double-blind study - Relapse prevention with escitalopram or nortriptyline following ECT (DUAG-7)

Danish University Antidepressant Group (DUAG)0 个研究点目标入组 300 人开始时间: 2008年10月28日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Remission of depression after Electroconvulsive Therapy (ECT)
  • Age above 18
  • ECT course ended within the last 21 days
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Suicidality corresponding to more than a score of more than 3 on the Hamilton depressionsskale item 3 or if project participant or investigator cannot determine the level of suicidality.
  • Manic symptoms of a severety corresponding to a score of 15 or more on the Bech-Rafaelsen Mania scale at inclusion and at any time during the study period.
  • Duration of current depressive episode of more than 2 years.
  • Participant is under coercive measures.
  • Dementia or any other known organic brain disease than is anticipated to influence the validity of the informed consent and compliance with the study.
  • Presence of known clinical important somatic diseases supposed to be problematic in relation to study procedures.
  • Epilepsia.
  • Cognitive deterioration caused by the Electroconvulsive therapy supposed to be problematic in relation to study procedures.
  • Schizophrenia, schizoaffektive disorder or other psychotic disorder without relation to actual depressive episdoe.
  • Bipolar I, Bipolar II or Rapid cy-cling bipolar sygdom.
  • Abuse of alcohol or other non-prescribed use of benzodiazepines
  • Current treatment with fluoxetine or within the last 6 weeks
  • Pregnancy or lactating.
  • Insufficient contraception.

研究者

发起方
Danish University Antidepressant Group (DUAG)

相似试验

Relapse prevention in patients with major depression... | 临床试验